172 related articles for article (PubMed ID: 35904556)
21. From peptides to small molecules: an intriguing but intricated way to new drugs.
Scognamiglio PL; Di Natale C; Perretta G; Marasco D
Curr Med Chem; 2013; 20(31):3803-17. PubMed ID: 23895692
[TBL] [Abstract][Full Text] [Related]
22. Display Selection of Exotic Macrocyclic Peptides Expressed under a Radically Reprogrammed 23 Amino Acid Genetic Code.
Passioura T; Liu W; Dunkelmann D; Higuchi T; Suga H
J Am Chem Soc; 2018 Sep; 140(37):11551-11555. PubMed ID: 30157372
[TBL] [Abstract][Full Text] [Related]
23. PepScaf: Harnessing Machine Learning with In Vitro Selection toward De Novo Macrocyclic Peptides against IL-17C/IL-17RE Interaction.
Zhai S; Tan Y; Zhang C; Hipolito CJ; Song L; Zhu C; Zhang Y; Duan H; Yin Y
J Med Chem; 2023 Aug; 66(16):11187-11200. PubMed ID: 37480587
[TBL] [Abstract][Full Text] [Related]
24. Automatic generation of functional peptides with desired bioactivity and membrane permeability using Bayesian optimization.
Fukunaga I; Matsukiyo Y; Kaitoh K; Yamanishi Y
Mol Inform; 2024 Apr; 43(4):e202300148. PubMed ID: 38182544
[TBL] [Abstract][Full Text] [Related]
25. A macrocyclic peptide that serves as a cocrystallization ligand and inhibits the function of a MATE family transporter.
Hipolito CJ; Tanaka Y; Katoh T; Nureki O; Suga H
Molecules; 2013 Aug; 18(9):10514-30. PubMed ID: 23999725
[TBL] [Abstract][Full Text] [Related]
26. The Road Ahead for the Development of Macrocyclic Peptide Ligands.
Passioura T
Biochemistry; 2020 Jan; 59(2):139-145. PubMed ID: 31592645
[TBL] [Abstract][Full Text] [Related]
27. mRNA display: from basic principles to macrocycle drug discovery.
Josephson K; Ricardo A; Szostak JW
Drug Discov Today; 2014 Apr; 19(4):388-99. PubMed ID: 24157402
[TBL] [Abstract][Full Text] [Related]
28. Biomedical Applications of a Novel Class of High-Affinity Peptides.
Saw PE; Xu X; Kim S; Jon S
Acc Chem Res; 2021 Sep; 54(18):3576-3592. PubMed ID: 34406761
[TBL] [Abstract][Full Text] [Related]
29. De novo peptide design and experimental validation of histone methyltransferase inhibitors.
Smadbeck J; Peterson MB; Zee BM; Garapaty S; Mago A; Lee C; Giannis A; Trojer P; Garcia BA; Floudas CA
PLoS One; 2014; 9(2):e90095. PubMed ID: 24587223
[TBL] [Abstract][Full Text] [Related]
30. Discovery and optimization of peptide macrocycles.
White AM; Craik DJ
Expert Opin Drug Discov; 2016 Dec; 11(12):1151-1163. PubMed ID: 27718641
[TBL] [Abstract][Full Text] [Related]
31. Using the QCM Biosensor-Based T7 Phage Display Combined with Bioinformatics Analysis for Target Identification of Bioactive Small Molecule.
Takakusagi Y; Takakusagi K; Sugawara F; Sakaguchi K
Methods Mol Biol; 2018; 1795():159-172. PubMed ID: 29846927
[TBL] [Abstract][Full Text] [Related]
32. Phage Selection of Cyclic Peptides for Application in Research and Drug Development.
Deyle K; Kong XD; Heinis C
Acc Chem Res; 2017 Aug; 50(8):1866-1874. PubMed ID: 28719188
[TBL] [Abstract][Full Text] [Related]
33. Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges.
Sawyer TK; Partridge AW; Kaan HYK; Juang YC; Lim S; Johannes C; Yuen TY; Verma C; Kannan S; Aronica P; Tan YS; Sherborne B; Ha S; Hochman J; Chen S; Surdi L; Peier A; Sauvagnat B; Dandliker PJ; Brown CJ; Ng S; Ferrer F; Lane DP
Bioorg Med Chem; 2018 Jun; 26(10):2807-2815. PubMed ID: 29598901
[TBL] [Abstract][Full Text] [Related]
34. Ribosomal Incorporation of Lithocholic Acid into Peptides for the
Song L; Liu H; Li M; Yang Y; Dong H; Li J; Shao J; Zhi L; Sun H; Li Z; Sui H; Zhang Y; Wu C; Yin Y
ACS Chem Biol; 2024 Jun; ():. PubMed ID: 38901034
[TBL] [Abstract][Full Text] [Related]
35. Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies.
Bashiruddin NK; Suga H
Curr Opin Chem Biol; 2015 Feb; 24():131-8. PubMed ID: 25483262
[TBL] [Abstract][Full Text] [Related]
36. Discovery of dipeptidyl peptidase 4 inhibitory peptides from Largemouth bass (Micropterus salmoides) by a comprehensive approach.
Wang K; Yang X; Lou W; Zhang X
Bioorg Chem; 2020 Dec; 105():104432. PubMed ID: 33157343
[TBL] [Abstract][Full Text] [Related]
37. Identification of small-molecule inhibitors against human leukocyte antigen-death receptor 4 (HLA-DR4) through a comprehensive strategy.
Liu Z; Li B; Li X; Zhang L; Lai L
J Chem Inf Model; 2011 Feb; 51(2):326-34. PubMed ID: 21284404
[TBL] [Abstract][Full Text] [Related]
38. Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening.
Kirstgen M; Müller SF; Lowjaga KAAT; Goldmann N; Lehmann F; Alakurtti S; Yli-Kauhaluoma J; Baringhaus KH; Krieg R; Glebe D; Geyer J
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452354
[TBL] [Abstract][Full Text] [Related]
39. Methodologies for Backbone Macrocyclic Peptide Synthesis Compatible With Screening Technologies.
Shinbara K; Liu W; van Neer RHP; Katoh T; Suga H
Front Chem; 2020; 8():447. PubMed ID: 32626683
[TBL] [Abstract][Full Text] [Related]
40. Lead discovery and optimization strategies for peptide macrocycles.
Bhat A; Roberts LR; Dwyer JJ
Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
